tradmap

BVS Earnings Bioventus Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$3 -$1 $0 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $287M $573M 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$159M -$68M $23M $0 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $1 $0 Q4 '22 Q3 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $79M $158M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$26M $4M $33M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–22 of 22
Q2 20262026-06-270.522026-08-0510-Q
Q1 20262026-03-280.042026-05-0610-Q
FY 20252025-12-310.332026-03-0510-K
Q3 20252025-09-270.122025-11-0410-Q
Q2 20262025-06-280.072026-08-0510-Q
Q1 20262025-03-29-0.042026-05-0610-Q
FY 20252024-12-31-0.562026-03-0510-K
Q3 20252024-09-28-0.562025-11-0410-Q
Q2 20252024-06-29-0.482025-08-0610-Q
Q1 20252024-03-30-0.082025-05-0610-Q
FY 20252023-12-31-2.492026-03-0510-K
Q3 20242023-09-30-2.402024-11-0510-Q
Q2 20242023-07-01-2.292024-08-0610-Q
Q1 20242023-04-01-2.242024-05-0710-Q
FY 20242022-12-31-2.592025-03-1110-K
Q3 20232022-10-01-2.072023-11-0710-Q
Q2 20232022-07-02-0.302023-08-0810-Q
Q1 20232022-04-02-0.192023-05-1610-Q
FY 20232021-12-31-0.152024-03-1210-K
Q3 20222021-10-02-0.152022-11-2110-Q
Q2 20222021-07-03-0.122022-08-1210-Q
Q1 20222021-04-03-0.022022-05-1110-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.